Nimitphong, H., Saetung, S., Chanprasertyotin, S., Chailurkit, L
For all the included studies, study quality was assessed using the standard NICE checklist, which evaluates 7 domains relating to randomization, blinding, imbalances between treatment groups, outcomes measured and reported, and handling of missing data
Can be combined with other treatments for enhanced results
GDF-8 1mg GDF-8 is involved in the regulation of myostatin activity, a key biological factor that normally limits muscle growth and regeneration
With the anti-obesity pharmacotherapy landscape rapidly evolving, two investigational agents from Eli Lilly have recently demonstrated highly promising Phase 2 results: Retatrutide (LY3437943) and Eloralintide (LY3841136)